elapsed_time: 18s
was_input_captured: True
original_text: |
    Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or not recovered from an adverse event caused by mAbs administered more than 4 weeks earlier
inclusion: False
